In this episode of Outperform Cancer, Marybeth Gilliam speaks with Dr. Ryan Polselli, a fellowship-trained breast imaging radiologist and founder and CEO of MammoLink, about why breast cancer screening still fails too many women — and what can be done to change that. For decades, women have been told that early detection saves lives. But too many breast cancers are still being diagnosed at later stages, when treatment is more difficult and outcomes are worse. Dr. Polselli explains that the issue is not simply whether mammograms work. The deeper problem is that the screening system is often too inconvenient, too fragmented, and not personalized enough for the women who need it. This conversation explores why annual mammograms matter, how dense breast tissue can make cancer harder to detect, why genetic risk should be identified before a cancer diagnosis whenever possible, and how mobile mammography may help close critical screening gaps. Dr. Polselli also explains how MammoLink is working to remove barriers by bringing breast imaging directly to workplaces and communities, offering a more accessible and patient-centered approach to early detection. Marybeth also shares her own experience of being diagnosed after insisting on additional testing despite a clear mammogram, reinforcing one of the most important takeaways from the episode: women should trust their bodies, understand their personal risk, and advocate for additional imaging or biopsy when something does not feel right. This episode is a call to rethink breast cancer screening as a strategy — one that combines annual screening, breast density awareness, genetic testing, risk assessment, better imaging, and easier access to help catch more cancers earlier. Episode Chapters 00:00 — Episode IntroMarybeth introduces the central question of the episode: if mammograms save lives, why are women still being diagnosed with late-stage breast cancer? She explains why early detection remains one of the most powerful tools in breast cancer care, and why screening needs to become more strategic and personalized. 03:50 — Meet Ryan PolselliDr. Ryan Polselli shares his background as a fellowship-trained breast imaging radiologist, former medical director of breast imaging, Navy veteran, and founder and CEO of MammoLink. He explains how his experience inside the healthcare system led him to focus on access, convenience, and better screening compliance. 07:52 — About MammoLinkDr. Polselli explains the mission behind MammoLink: to remove the barriers that prevent women from getting screened. By bringing mobile mammography directly to workplaces and communities, MammoLink is designed to make breast cancer screening easier, faster, and more patient-centered. 22:07 — Importance of Annual ScreeningsMarybeth and Dr. Polselli discuss why annual mammograms matter and why reported screening compliance statistics can be misleading. They explore how delayed or skipped screenings can contribute to later-stage diagnoses, and why women should not assume that a “normal” mammogram means they can ignore new symptoms. 37:00 — How Patients Can Judge QualityDr. Polselli explains what patients should look for when evaluating the quality of a breast imaging center, including whether mammograms are read by breast imaging specialists, whether 3D mammography is available, how callback rates are handled, and why same-day follow-up imaging can reduce anxiety and improve the patient experience. 38:39 — Mammograms and Healthcare CostsThe conversation turns to healthcare costs, reimbursement incentives, and contrast-enhanced mammography. Dr. Polselli discusses how financial structures can influence patient pathways and why some useful tools may be underused even when they could make screening easier or more effective for patients. 43:22 — Breast Cancer in MenMarybeth and Dr. Polselli discuss the often-overlooked issue of breast cancer in men. While routine screening is not generally recommended for most men, Dr. Polselli emphasizes that men can develop breast cancer and should never ignore a breast lump or symptom — especially if they have a genetic risk such as a BRCA mutation. 47:55 — Postpartum and Final TakeawaysMarybeth and Dr. Polselli discuss postpartum and pregnancy-associated breast cancer, including why lumps during or after pregnancy should be taken seriously. The episode closes with a clear message: know your risk, get screened, understand breast density, consider genetic testing when appropriate, and advocate for yourself if something feels wrong. Key Takeaways Annual mammograms matter, but the system needs to make screening easier for women to complete every year. Breast density can make cancer harder to detect on mammography, which is why some women may benefit from supplemental imaging such as ultrasound or MRI. Genetic testing is often done after a breast cancer diagnosis, but for many patients, that information could be far more powerful before cancer develops. A “normal” mammogram does not mean women should ignore a new lump, breast texture change, or symptom. Patients can ask whether their mammograms are being read by a fellowship-trained breast imaging radiologist or a breast imaging specialist. Mobile mammography may help close screening gaps by making breast imaging more accessible, convenient, and patient-centered. Men can get breast cancer too, and men with breast lumps or strong family history should take symptoms seriously. Postpartum breast cancer is an important and under-discussed risk area, and young mothers should not dismiss breast changes as “just pregnancy” or “just breastfeeding.” Connect with Dr. Ryan Polselli and MammoLink Learn more about MammoLink and Dr. Ryan Polselli’s work to make breast cancer screening more accessible, personalized, and patient-centered: MammoLink Website: https://www.mammolink.com/Facebook: https://www.facebook.com/DrRyanPolselliLinkedIn: http://linkedin.com/in/ryanpolselliInstagram: https://www.instagram.com/ryanpolselli/ If you found this valuable, LIKE, SUBSCRIBE, and SHARE to help others access anti-cancer strategies. YouTube: https://www.youtube.com/@OutperformCancer Facebook: https://www.facebook.com/outperformcancer/ LinkedIn: https://www.linkedin.com/company/outperform-cancer/ Instagram: https://www.instagram.com/marybethgilliam/
